Former President Clinton announced on Thursday in New York City that he is establishing a fund to educate and train breast cancer survivors in order to further research on the disease and increase access to care, the AP/Newark Star-Ledger reports. The Virginia Clinton Kelley Fund will be established in honor of his mother, who died of the disease in 1994, and will be part of the National Breast Cancer Coalition Fund. NBCCF President Fran Visco said the new fund will support "high-risk" research, such as the development and testing of Herceptin, which is the first drug to specifically target breast cancer. Clinton said of his mother, "She was totally at ease with her own mortality and yet ferocious in fighting against the disease," adding, "Basically, we're going to train people to do what she did by second nature. We're doing better with breast cancer, but we've still got a long way to go" (Marchione, AP/Newark Star-Ledger, 11/4).
"Reprinted with permission from kaisernetwork. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at kaisernetwork/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
View drug information on Herceptin.
Комментариев нет:
Отправить комментарий